Abstract:Objectives:To investigate vascular macrophage phenotype as well as vascular and peripheral chemokine (C-C motif) ligand 2 (CCL2) expression during different stages of disease progression in patients with Takayasu Arteritis (TA).Methods:In this study, 74 patients with TA and 50 controls were recruited. TA disease activity was evaluated with Kerr scores. Macrophage phenotype and CCL2 expression were examined by immunohistochemistry in vascular specimens from 8 untreated and 7 treated TA patients, along with 4 healthy controls. Serum CCL2 were quantified by enzyme-linked immune-absorbent assay from TA patients at baseline (n=59), at 6-months (n=38), and from 46 healthy volunteers. Vascular macrophage phenotype, vascular CCL2 expression and serum CCL2 levels during different stages, as well as the relationship between serum CCL2 and disease activity or other inflammatory parameters (erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), and interleukin 6 (IL-6)) were investigated.Results:In untreated patients, vascular M1 macrophages and CCL2 showed increased expression, mainly in the adventitia. In contrast, in treated patients, vascular adventitial M1 and CCL2 expression were decreased, while vascular medial M2 macrophages and CCL2 levels were increased. Distribution of macrophages and CCL2 was consistent within the TA vascular lesions regardless of the disease stage. Furthermore, peripheral CCL2 was elevated in patients with TA (TA: 160.30 ± 120.05 vs. Control: 65.58 ± 54.56 pg/ml, P < 0.001). CCL2 levels were found to correlate with ESR, CRP, and IL-6 (all R values between 0.55 and 0.6, all P < 0.001). Receiver operating curve analysis demonstrated that CCL2 (at the cut-off value of 100.36 pg/ml) was able to predict disease activity (area under the curve = 0.74, P = 0.03). Decrease in CCL2 level was observed in patients with clinical remission (CR), but not in patients without CR, after 6 months of treatment (CR patients: baseline 220.18 ± 222.69 vs. post-treatment 88.71 ± 55.89 pg/ml, P = 0.04; non-CR patients: baseline 142.45 ± 104.76 vs. post-treatment 279.49 ± 229.46 pg/ml, P = 0.02).Conclusions:Macrophages contribute to vascular pathological changes in TA by undergoing phenotype transformation. CCL2 is an important factor for recruiting macrophages and a potential biomarker for disease activity.

Association between serum adipokine profile and vascular inflammation in patients with Takayasu arteritis

Baseline Adiponectin and Leptin Levels in Predicting an Increased Risk of Disease Activity in Rheumatoid Arthritis: A Meta-Analysis and Systematic Review

Serum Leptin, a Potential Predictor of Long‐term Angiographic Progression in Takayasu’s Arteritis

Serum Levels of IL-1, TNF-α, IL-2, IFN-γ and Neopterin in Patients with Rheumatoid Arthritis

MMP-9 and IL-6 Are Potential Biomarkers for Disease Activity in Takayasu's Arteritis

Study on the Relationship between Serum Resistin and Acute Coronary Syndrome and Stable Angina Pectoris

Dysregulated serum lipid profile and atherosclerosis in untreated female TA patients: a PSM analysis

Enhanced Liver Fibrosis Score as a Biomarker for Vascular Damage Assessment in Patients with Takayasu Arteritis—A Pilot Study

YKL-40 As a New Biomarker of Disease Activity in Takayasu Arteritis.

Exploration of Molecular Signatures Associated with Different Clinical Features of Takayasu Arteritis Based on a Prospective Cohort Study.

Serum concentrations of small dense low‐density lipoprotein cholesterol and lipoprotein(a) are related to coronary arteriostenosis in Takayasu arteritis

Assessment of Low Bone Mineral Density in Untreated Patients with Takayasu's Arteritis.

Novel Biomarkers for the Precisive Diagnosis and Activity Classification of Takayasu Arteritis

Clinicial features of Takayasu arteritis: a cohort study

Decreased Absolute Number of Circulating Regulatory T Cells in Patients With Takayasu’s Arteritis

Potential Role of Macrophage Phenotypes and CCL2 in the Pathogenesis of Takayasu Arteritis.

Radiology and Biomarkers in Assessing Disease Activity in Takayasu Arteritis

Adipocytokines in Untreated Newly Diagnosed Rheumatoid Arthritis: Association with Circulating Chemokines and Markers of Inflammation

Retrospective Study of 67Patients with Takayasu Arteritis

Vascular calcification in Takayasu arteritis: relationship with metabolic syndrome, left ventricular mass index, and intima-media thickness